Even after backtracking on its cut of funds for Planned Parenthood, the fallout for the Susan G. Komen for the Cure Foundation continues this morning with publicity public policy senior vice president Karen Handel's sour-sounding resignation. Handel, of course, was the one-time pro-life activist and gubernatorial candidate in Georgia largely implicated in pushing the organization to drop its funding for Planned Parenthood, which among other services provides abortions.  And while CEO and founder Nancy Brinker told MSNBC that Handel "didn't have a significant role" in the decision and Handel (who hadn't publicly commented until today) said that discussion of cutting ties with Planned Parenthood predate her tenure at Komen, she defends the breast-cancer foundation's old stance against Planned Parenthood even while the foundation no longer does. An excerpt from her resignation letter:

I am deeply disappointed by the gross mischaracterizations of the strategy, its rationale, and my involvement in it. I openly acknowledge my role in the matter and continue to believe our decision was the best one for Komen’s future and the women we serve. 

...

What was a thoughtful and thoroughly reviewed decision – one that would have indeed enabled Komen to deliver even greater community impact – has unfortunately been turned into something about politics. This is entirely untrue. This development should sadden us all greatly.

Those heavy and some would say bitter words are tempered by one fact, though. She decided to turn down a severance package.
 
Here is Handel's full resignation letter:
 

The Honorable Nancy Brinker
CEO, Susan G. Komen for the Cure VIA EMAIL
5005 LBJ Freeway, Suite 250
Dallas, Texas 75244
 

Dear Ambassador Brinker:

Susan G. Komen for the Cure has been the recognized leader for more 30 years in the fight against breast cancer here in the US – and increasingly around the world.

As you know, I have always kept Komen’s mission and the women we serve as my highest priority – as they have been for the entire organization, the Komen Affiliates, our many supporters and donors, and the entire community of breast cancer survivors. I have carried out my responsibilities faithfully and in line with the Board’s objectives and the direction provided by you and Liz.

We can all agree that this is a challenging and deeply unsettling situation for all involved in the fight against breast cancer. However, Komen’s decision to change its granting strategy and exit the controversy surrounding Planned Parenthood and its grants was fully vetted by every appropriate level within the organization. At the November Board meeting, the Board received a detailed review of the new model and related criteria. As you will recall, the Board specifically discussed various issues, including the need to protect our mission by ensuring we were not distracted or negatively affected by any other organization’s real or perceived challenges. No objections were made to moving forward.

I am deeply disappointed by the gross mischaracterizations of the strategy, its rationale, and my involvement in it. I openly acknowledge my role in the matter and continue to believe our decision was the best one for Komen’s future and the women we serve. However, the decision to update our granting model was made before I joined Komen, and the controversy related to Planned Parenthood has long been a concern to the organization. Neither the decision nor the changes themselves were based on anyone’s political beliefs or ideology. Rather, both were based on Komen’s mission and how to better serve women, as well as a realization of the need to distance Komen from controversy. I believe that Komen, like any other nonprofit organization, has the right and the responsibility to set criteria and highest standards for how and to whom it grants.

What was a thoughtful and thoroughly reviewed decision – one that would have indeed enabled Komen to deliver even greater community impact – has unfortunately been turned into something about politics. This is entirely untrue. This development should sadden us all greatly.

Just as Komen’s best interests and the fight against breast cancer have always been foremost in every aspect of my work, so too are these my priorities in coming to the decision to resign effective immediately. While I appreciate your raising a possible severance package, I respectfully decline. It is my most sincere hope that Komen is allowed to now refocus its attention and energies on its mission.